BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bekhite MM, Schulze PC. Human Induced Pluripotent Stem Cell as a Disease Modeling and Drug Development Platform-A Cardiac Perspective. Cells 2021;10:3483. [PMID: 34943991 DOI: 10.3390/cells10123483] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Hsueh YC, Pratt RE, Dzau VJ, Hodgkinson CP. Novel method of differentiating human induced pluripotent stem cells to mature cardiomyocytes via Sfrp2. Sci Rep 2023;13:3920. [PMID: 36894665 DOI: 10.1038/s41598-023-31144-3] [Reference Citation Analysis]
2 Zhang F, Meier AB, Poch CM, Tian Q, Engelhardt S, Sinnecker D, Lipp P, Laugwitz K, Moretti A, Dorn T. High-throughput optical action potential recordings in hiPSC-derived cardiomyocytes with a genetically encoded voltage indicator in the AAVS1 locus. Front Cell Dev Biol 2022;10:1038867. [DOI: 10.3389/fcell.2022.1038867] [Reference Citation Analysis]
3 Song Y, Zheng Z, Lian J. Deciphering Common Long QT Syndrome Using CRISPR/Cas9 in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Front Cardiovasc Med 2022;9:889519. [DOI: 10.3389/fcvm.2022.889519] [Reference Citation Analysis]